Niemcy zgłaszają Sputnika V do europejskiej rejestracji w EMA
EMA’s human medicines committee (CHMP) has started a rolling review of Sputnik V (Gam-COVID-Vac), a COVID-19 vaccine1 developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology. The EU applicant for this medicine is R-Pharm Germany GmbH.
k.....x z- #
- #
- #
- #
- #
- #
- 2
Komentarze (2)
najlepsze
On October 1, 2014, a new chapter in the successful history of the company was opened.
//